ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Report On Carcinogenesis Testing, Evaluation Submitted to NTP; Calls For Continued Research

September 7, 1984

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

Four NCAB Appointments Announced, Including Durant, Fisher; White House Delays On Others

April 4, 1986

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002